Forte Stock Analysis

FBRX -  USA Stock  

USD 29.79  0.96  3.12%

The small slide in market price for the last few months could raise concerns from investors as the firm it trading at a share price of 29.79 on 299,275 in volume. The company executives did not add much value to Forte Biosciences investors in July. However, diversifying your holdings with Forte Biosciences or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.73. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Forte Biosciences partners.
Please check Investing Opportunities.

Search Stock Analysis 

 
Refresh
The Forte Biosciences stock analysis report makes it easy to digest most publicly released information about Forte Biosciences and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Forte Stock analysis module also helps to analyze the Forte Biosciences price relationship with some important fundamental indicators such as market cap and management efficiency.

Forte Stock Analysis Notes

About 28.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Forte Biosciences had a split on the 16th of June 2020. Forte Biosciences Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company was incorporated in 2007 and is based in Torrance, California. Forte Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people. To learn more about Forte Biosciences call the company at 310 618 6994 or check out http://www.fortebiorx.com/home/default.aspx.

Forte Biosciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Forte Biosciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Forte Biosciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Forte Biosciences generates negative expected return over the last 90 days
Forte Biosciences has high historical volatility and very poor performance
Forte Biosciences has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (49.24 M).
Forte Biosciences currently holds about 54.76 M in cash with (19.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.05.
Roughly 61.0% of the company shares are owned by institutional investors
Latest headline from www.equities.com: Forte Bio falls 0.07 percent on Moderate Volume July 30 - Equities.com

Forte Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 396.43 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Forte Biosciences's market, we take the total number of its shares issued and multiply it by Forte Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (34.06) % which means that it has lost $34.06 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (168.52) %, meaning that it created substantial loss on money invested by shareholders. Forte Biosciences management efficiency ratios could be used to measure how well forte biosciences manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 3rd of August, Forte Biosciences shows the Coefficient Of Variation of 21133.14, mean deviation of 3.31, and Downside Deviation of 4.68. Forte Biosciences technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Forte Biosciences, which can be compared to its rivals. Please confirm Forte Biosciences variance and potential upside to decide if Forte Biosciences is priced favorably, providing market reflects its regular price of 29.79 per share. Given that Forte Biosciences has jensen alpha of 0.0192, we urge you to verify Forte Biosciences's prevailing market performance to make sure the company can sustain itself at a future point.

Forte Biosciences Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Forte Biosciences price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average. View also all equity analysis or get more info about triple exponential moving average t3 overlap studies indicator.

Forte Biosciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Forte Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Forte Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Forte Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Forte Biosciences Predictive Daily Indicators

Forte Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Forte Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Forte Biosciences Forecast Models

Forte Biosciences time-series forecasting models is one of many Forte Biosciences' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Forte Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Forte Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Forte Biosciences stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Forte shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Forte Biosciences. By using and applying Forte Stock analysis, traders can create a robust methodology for identifying Forte entry and exit points for their positions.
Forte Biosciences Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company was incorporated in 2007 and is based in Torrance, California. Forte Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Forte Biosciences to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Premium Stories Now

   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
All  Next Launch Module
Please check Investing Opportunities. Note that the Forte Biosciences information on this page should be used as a complementary analysis to other Forte Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for Forte Stock analysis

When running Forte Biosciences price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
The market value of Forte Biosciences is measured differently than its book value, which is the value of Forte that is recorded on the company's balance sheet. Investors also form their own opinion of Forte Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Forte Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Forte Biosciences' market value can be influenced by many factors that don't directly affect Forte Biosciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Forte Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Forte Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Forte Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.